XML 35 R20.htm IDEA: XBRL DOCUMENT
v3.22.2

Loss Per Common Share | 6 Months Ended
--- | ---
Jun. 30, 2022
Earnings Per Share [Abstract] |
Loss Per Common Share | Loss Per Common Share The following table sets forth the computation of basic and diluted earnings per share available for common stockholders (in thousands, except per share data):
| For the Three Months Ended June 30, |  | For the Six Months Ended June 30,
| 2022 |  | 2021 |  | 2022 |  | 2021
Loss from continuing operations | $ | (4,125) |  |  | $ | (9,107) |  |  | $ | (9,475) |  |  | $ | (20,297) |
Income (loss) from discontinued operations, net of tax | (463) |  |  | — |  |  | (463) |  |  | 1,383 |
Net loss attributable to common shareholders of Evolent Health, Inc. | $ | (4,588) |  |  | $ | (9,107) |  |  | $ | (9,938) |  |  | $ | (18,914) |
Weighted-average common shares outstanding - basic and diluted | 90,071 |  |  | 85,448 |  |  | 89,792 |  |  | 85,056 |
Loss per common share |  |  |  |  |  |  |
Basic and diluted |  |  |  |  |  |  |
Continuing operations | $ | (0.05) |  |  | $ | (0.11) |  |  | $ | (0.11) |  |  | $ | (0.24) |
Discontinued operations | — |  |  | — |  |  | — |  |  | 0.02 |
Basic and diluted loss per share attributable to common shareholders of Evolent Health, Inc. | $ | (0.05) |  |  | $ | (0.11) |  |  | $ | (0.11) |  |  | $ | (0.22) |
Anti-dilutive shares excluded from the calculation of weighted-average common shares presented above are presented below (in thousands):
| For the Three Months Ended June 30, |  | For the Six Months Ended June 30,
| 2022 |  | 2021 |  | 2022 |  | 2021
Restricted stock units ("RSUs"), performance-based RSUs (“PSUs”) and leveraged stock units ("LSUs") | 1,642 |  |  | 2,052 |  |  | 1,817 |  |  | 1,793 |
Stock options | 1,852 |  |  | 1,801 |  |  | 1,807 |  |  | 1,833 |
Convertible senior notes | 11,582 |  |  | 12,696 |  |  | 11,582 |  |  | 12,696 |
Total | 15,076 |  |  | 16,549 |  |  | 15,206 |  |  | 16,322 |

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 3 -URI https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -URI https://asc.fasb.org/topic&trid=2144383 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 2 -URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration